Search
forResearch 10 of 1000+
- The utilisation of cardiac risk ratio and non-HDL cholesterol markers to assess cardiovascular risk in type 2 diabetes males with lowered serum DHT
- Androgenic alopecia; the risk–benefit ratio of Finasteride
- Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity
- Cardiovascular and Metabolic Risk Profiles Across Different Phenotypes of Polycystic Ovary Syndrome
- Association between air quality index and risk of alopecia areata: A nationwide population-based cohort study
- Is polycystic ovary syndrome a risk factor for depression and anxiety?: a cross-sectional study
- Longer TA repeat but not V89L polymorphisms in the SRD5A2 gene may confer acne risk in the Chinese population
- Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome
- Impact of lisinopril on cardiometabolic risk factors in men with hypertension and early-onset androgenetic alopecia
- Is Prenatal Sex Hormone Balance a Risk Factor for the Development of Hidradenitis Suppurativa
Community 10 of 91
- Just Like France Belgium disagrees with EMA and will veto against Finasteride
- Why don’t people just just DUT instead of FIN?
- DUT Risk profile for having kids?
- How much more risk does TRT really put on hair?
- Is microneedling a risk if you want to have a hair transplant in the future?
- Should I risk changing to Dutasteride?
- Finasteride is a risk in pregnancy with unprotected sex
- Weight loss drugs linked to increased risk of hair loss, researchers say
- Finasteride Concerns: Nipple Sensitivity and Gyno Risk at 23M
- Publication concludes finasteride is a associated with a 60% risk of persistent sexual dysfunction.